More recently, in a model of Alzheimer’s disease using amyloid precursor protein (APP) overexpressed neuroblastoma cells, newly synthesised imidazoquinazolinone TSPO ligands were able to reduce oxidative injury by decreasing ROS generation in response to H2O2 stimulation. Here, APP is linked to neuroblastoma.